Lennart Erik Jonas Sjögren
Directeur/Membre du Conseil chez STORYTEL AB
Fortune : 872 420 $ au 31/05/2024
Profil
Mr. Lennart Erik Jonas Sjögren is an Independent Director at Storytel AB, a Chairman at Exceca Allocation AB, a Head-Investments at Exceca AB, a Chairman at Alsteron AB, a Chairman at Markov Capital AB, a Chief Executive Officer & Director at Bauer Media Holding Oy and a Deputy Director at Delibr AB.
He is on the Board of Directors at Storytel AB, Bauer Media Holding Oy, CMC SPV of 3 April 2017 AB, Oblique Therapeutics AB, Omentum, Orbit E Sport AB and Vakona AB.
Mr. Sjögren was previously employed as an Independent Director by Alligator Bioscience AB and a Manager-Product Management Department by Ericsson AB.
He also served on the board at Storytel Sweden AB, smartphoto group NV, Battleriff Gaming AB, Roxette Photo NV, Storytel AB /Old/ and Tellander Holding AB.
He received his graduate degree from Chalmers University of Technology, an MBA from INSEAD and a doctorate degree from Sahlgrenska University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLIGATOR BIOSCIENCE AB
1,12% | 31/12/2023 | 8 511 419 ( 1,12% ) | 872 420 $ | 31/05/2024 |
Postes actifs de Lennart Erik Jonas Sjögren
| Sociétés | Poste | Début |
|---|---|---|
| STORYTEL AB | Directeur/Membre du Conseil | 04/05/2023 |
| Markov Capital AB | Président | - |
| Alsteron AB | Président | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Delibr AB
 Delibr AB Miscellaneous Commercial ServicesCommercial Services Delibr AB is a startup based in Stockholm, Sweden that helps product managers and their teams collaborate better in their feature refinement process. The Swedish company offers fair pricing and only charge for active users in the previous month. New users can start with a 14-day free trial without needing to provide credit card information. Nils Janse has been the CEO of the company since 2013. | Corporate Officer/Principal | - |
| Exceca Allocation AB | Président | - |
| CMC SPV of 3 April 2017 AB | Directeur/Membre du Conseil | - |
| Omentum | Directeur/Membre du Conseil | - |
| Orbit E Sport AB | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Lennart Erik Jonas Sjögren
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Lennart Erik Jonas Sjögren
| INSEAD | Masters Business Admin |
| Chalmers University of Technology | Graduate Degree |
| Sahlgrenska University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SMARTPHOTO GROUP NV | Retail Trade |
| STORYTEL AB | Consumer Services |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Entreprise privées | 17 |
|---|---|
Storytel AB /Old/
 Storytel AB /Old/ Miscellaneous Commercial ServicesCommercial Services Storytel AB provides electronic media services. The company offers audio book services for streaming and listening on mobile phones. Storytel was founded in 2006 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Exceca AB | |
Bauer Media Holding Oy
 Bauer Media Holding Oy BroadcastingConsumer Services Bauer Media Holding Oy provides radio programming services. The company was founded on June 30, 1992 and is headquartered in Helsinki, Finland. | Consumer Services |
| Orbit E Sport AB | |
Roxette Photo NV
 Roxette Photo NV Financial ConglomeratesFinance Roxette Photo NV is an investment holding Belgian company founded in 1989. The private company is based in Luxemburg, Belgium. | Finance |
| Omentum | Miscellaneous |
| Tellander Holding AB | |
Battleriff Gaming AB
 Battleriff Gaming AB Internet Software/ServicesTechnology Services Battleriff Gaming AB operates as an entertainment gaming club. The firm offers online games, such as FIFA, league of legends, smite and hearthstone. The company was founded by Mathias Lindmark, Antony Sastre, Elias Löfgren, and Simon Hagert in 2014 and is headquartered in Gothenburg, Sweden. | Technology Services |
| CMC SPV of 3 April 2017 AB | |
| Exceca Allocation AB | |
Delibr AB
Delibr AB Miscellaneous Commercial ServicesCommercial Services Delibr AB is a startup based in Stockholm, Sweden that helps product managers and their teams collaborate better in their feature refinement process. The Swedish company offers fair pricing and only charge for active users in the previous month. New users can start with a 14-day free trial without needing to provide credit card information. Nils Janse has been the CEO of the company since 2013. | Commercial Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Health Technology |
| Alsteron AB | Finance |
| Markov Capital AB | |
Storytel Sweden AB
 Storytel Sweden AB Publishing: Books/MagazinesConsumer Services Storytel Sweden AB operates as digital subscription service that stream audiobooks to mobile phone. It also publishes own books under the name Storyside. The company was founded by Jon Hauksson and Per Jonas Tellander in 2005 and is headquartered in Stockholm, Sweden. | Consumer Services |
Ericsson AB
 Ericsson AB Information Technology ServicesTechnology Services Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden. | Technology Services |
Vakona AB
 Vakona AB BiotechnologyHealth Technology Vakona is a Swedish company that is developing a new biological drug for the treatment of acne. The drug is based on a bacterial enzyme and has the potential to significantly reduce treatment time and side effects such as skin irritation. The company's research is based on over a decade of work by Dr. Oleg Alexeyev and aims to provide an alternative to the long-term inefficacy of current acne therapies that rely on antibiotics. The company was founded by Oleg Alexeyev and has CEOs Mats Olof Strömqvist and Gabriella Persson. | Health Technology |
